<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-143428" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Visual Evoked Potential</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Baiano</surname>
            <given-names>Cinzia</given-names>
          </name>
          <aff>Neurosurgery "Federico II"</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Zeppieri</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>University Hospital of Udine, Italy</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Cinzia Baiano declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Zeppieri declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>11</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-143428.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Visual evoked potentials (VEPs) represent a valid electrophysiological tool in neurological pathologies. VEPs are the expression of the electrical activity of the visual pathways up to the optic nerve to the calcarine cortex. These potentials provide a non-invasive exploration method of the functionality of the human visual system through detecting neuronal pool activity responding to stimuli independently of the consciousness and attention state of the patient. VEPs have a clinical application in ophthalmological retinal pathology and neurological pathology related to the optic nerve and/or brain. VEPs have been used as an alternative method to assess visual acuity in non-verbal infants and adults with low intellectual abilities or potential malingerers and for surgical intra-operative monitoring. This activity describes the role of this instrumental examination in the diagnosis and follow-up of neurological and ophthalmological pathologies by the interprofessional team.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the main type of VEPs used in studying neurological pathologies affecting the visual pathways.</p></list-item><list-item><p>Identify the main degenerative disease explored by VEPs.</p></list-item><list-item><p>Explain VEPs alterations in multiple sclerosis.</p></list-item><list-item><p>Summarize the technical principles of VEPs.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143428&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143428">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-143428.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Visual evoked potentials (VEP)s represent a valid electrophysiological tool in neurological pathologies. VEPs are the expression of the electrical activity of the visual pathways up to the optic nerve to the calcarine cortex.<xref ref-type="bibr" rid="article-143428.r1">[1]</xref></p>
        <p>These potentials provide a non-invasive exploration method of the functionality of the human visual system through detecting neuronal pool activity responding to stimuli independently of the consciousness and attention state of the patient. The measurement of VEP is made possible by applying electrodes on the scalp in the occipital region and administering visual stimuli in a patient with open eyes.<xref ref-type="bibr" rid="article-143428.r1">[1]</xref><xref ref-type="bibr" rid="article-143428.r2">[2]</xref>&#x000a0;</p>
        <p>Depending on the characteristics of the stimulus, pattern visual evoked potentials can provide different information on the functionality of the various sectors of the visual field and the integrity of the optical pathways.&#x000a0;This type of instrumental exploration has a clinical application in ophthalmological retinal pathology and neurological pathology related to the optic nerve and/or brain (inflammatory, atrophic, toxic, tumoral, and genetic disease). VEPs has been used as an alternative method to assess visual acuity in non-verbal infants and adults with low intellectual abilities or potential malingering.<xref ref-type="bibr" rid="article-143428.r3">[3]</xref><xref ref-type="bibr" rid="article-143428.r4">[4]</xref><xref ref-type="bibr" rid="article-143428.r5">[5]</xref></p>
      </sec>
      <sec id="article-143428.s3" sec-type="Function">
        <title>Function</title>
        <p>
<bold>Technical Notions</bold>
</p>
        <p>The main type of VEPs used in studying neurological pathologies affecting the visual pathways is VEP structured with a stimulation model (pattern-VEP or P-VEP). Generally, it is a "reversal" pattern (reversal-P-VEP), in which the light and dark elements of the model are organized to form a chessboard or bars. The stimuli are reversed, allowing contrast variations with constant average luminance. Another type of VEP with an "onset-offset" pattern (onset-offset-P-VEP) is based on a visual stimulus that appears and disappears in a sequence always characterized by a constant average luminance.</p>
        <p>VEPs that use a diffuse flash stimulus (flash-VEP or F-VEP) characterized by a variation in brightness, however, have a rather limited field of application in the field of neurological pathologies affecting the visual pathways considering that this testing method offers extremely variable responses in the normal individuals and are less sensitive than P-VEP. Furthermore, P-VEPs allow for the selection of characteristics for the most suitable stimulus in the clinical analysis of the different components of the visual system, which can be activated differently according to the spatial, temporal, chromatic, and contrast properties of the image.<xref ref-type="bibr" rid="article-143428.r6">[6]</xref><xref ref-type="bibr" rid="article-143428.r7">[7]</xref> (See Figures of instrumentation, testing, stimulator, and results of VEPs)</p>
        <p>The spatial frequency (SF) of a pattern stimulus measures how many times the contrast of an image changes from the minimum to the maximum value in a degree of visual angle, which is then measured in cycles per degree (c / d), where 1 c / g corresponds to the complete alternation from a light element to a dark one in a degree of visual angle.</p>
        <p>The size of the bar (w) can be calculated by the formula: w = 60/2f, where w is expressed in arc minutes and f is the SF expressed in c/d. If instead of bars, the model used is a chessboard, the dimensions of the chessboards are measured in arc minutes of the degree of visual angle. The different SFs permit the exploration of the different sectors of the visual field by stimulating the different neuronal systems of the visual pathway physiologically.<xref ref-type="bibr" rid="article-143428.r8">[8]</xref>&#x000a0;</p>
        <p>The electrophysiological response obtained with a potential depends on the luminance of the stimulus, the contrast between the two stimuli (luminance difference), and the temporal frequency. P-VEP amplitude increases linearly with increasing contrast and disappears for contrasts equal to or less than 10% when the difference between light and dark elements is no longer recognizable.&#x000a0;If VEPs are recorded according to an offset/onset stimulus, the background luminance of the offset stimulus must be identical to that of the structured stimulus (onset stimulus).</p>
        <p>The contrast (C) between the elements of the pattern corresponds to the difference in luminance between the light and dark elements and is expressed in percentage values. The electrophysiological response obtained with a P-VEP depends on the temporal frequency, that is, on the speed with which the pattern appears or disappears (onset-off-set-P-VEP) or with which the elements of the model reverse their position (reversal-P-VEP). The variation of the temporal frequency with which the elements reverse each other at low frequencies (&#x0003c;4 Hz) is considered a "transient" type response, while at high frequencies (&#x0003e;4 Hz), the response type is defined as a "steady state."<xref ref-type="bibr" rid="article-143428.r9">[9]</xref></p>
        <p>In the reversal-P-VEP,&#x000a0; low stimulation FTs (between 1 Hz and 4 Hz) are currently used, allowing precise recording from the occipital cortex. This electrophysiological response is known as "transient" response.&#x000a0;The "transient" potential of the reversal-P-VEP consists of three deflections of the electrical signal with an alternating polarity of reproducible latency and morphology, in which it is possible to recognize a positive main component with a latency of about 100 ms (potential P 100), preceded and followed by two negative components, with a latency of about 70&#x000a0;to 75 ms (potential N 75) and 130&#x000a0;to 145 ms (potential N 140) respectively. The positive component P100 represents the most stable and repeatable response of this P-potential, recordable on all scalp regions that correspond to the occipital cortex, with its maximum amplitude along the midline, at the inion.</p>
        <p>Numerous studies have identified P100 as the electrical correlate of the activity of the primary visual cortex. For lesions of the optic pathways with cortical saving, it is still possible to record an intact P100.&#x000a0;The other two negative components of the potential (N140 and N70) could instead have generators at the level of the striatal cortex (N70) and extra-striatal (N140), which tend not to be useful in clinical practice.<xref ref-type="bibr" rid="article-143428.r9">[9]</xref><xref ref-type="bibr" rid="article-143428.r10">[10]</xref><xref ref-type="bibr" rid="article-143428.r11">[11]</xref> (See Figures of VEPs results)</p>
        <p>
<bold>Applications</bold>
</p>
        <p>In a routine clinical setting, the P-VEP stimulation pattern is obtained through the simultaneous stimulation of the two visual hemifields on the sides of the fixation center (whole-field stimulation) while the recording electrodes are positioned on the occipital scalp at Oz (International Electroencephalographic System 10-20) and on two symmetrical points placed laterally 5&#x000a0;to 7 cm away from the central one.</p>
        <p>The potentials recorded by the laterally placed electrodes are generally variable and less represented; therefore, amplitude and latency parameters are regularly acquired considering the central electrode. The evaluations of the morphology, amplitude, and above all, the latency (retino-cortical conduction time) of the P100 potential represent the fundamental element for the electrophysiological study of the integrity of the optical pathways, especially at the pre-chiasmatic level.</p>
        <p>The reduction of the sensitivity of the visual field due to damage to the retro-orbital nerve structures (optic nerve) determines alterations of the P-PEV that are reflected as a decrease in amplitude and/or in a lengthening of the latency time of the different components that make up the potential. The variations in amplitude and latency of PEVs represent precisely the electrophysiological correlate of different pathological phenomena that affect the optical pathways.</p>
        <p>The topographic position, size, and degree of the campimetric deficit strictly condition any anomalies detected in the analysis of the P-PEV. Lesions of the optic nerve associated with relative scotomas in the macular area can cause significant alterations of the P-VEP recorded by the scalp, while an absolute scotoma, even if extensive but localized in the peripheral region of the visual field, can modify the P-VEP in a minimal or even null way.<xref ref-type="bibr" rid="article-143428.r12">[12]</xref></p>
      </sec>
      <sec id="article-143428.s4" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>P-VEPs represent a sensitive indicator of abnormalities in the integrity of the entire visual system, which can be the subject of demyelinating or axonal pathologies. Depending on the type of pathogenetic mechanism, P-VEPs can signal the presence of demyelination phenomena, expressed by changes in latency and an increase in retinol-cortical conduction time, as well as indicating the existence of axonal damage evidenced by alterations in the amplitude and morphology of the acquired responses. According to these principles, P-VEPs are used to diagnose pre-chiasmatic, chiasmatic, and retrochiasmatic neurological pathologies.<xref ref-type="bibr" rid="article-143428.r13">[13]</xref><xref ref-type="bibr" rid="article-143428.r14">[14]</xref><xref ref-type="bibr" rid="article-143428.r15">[15]</xref></p>
        <p>
<bold>Neuropthalmological Field</bold>
</p>
        <p>VEPs are used in the field of neuro-ophthalmology for several clinical applications, which include: the quantification and monitoring of functional damage in optical neuropathies of different inflammatory, demyelinating, compressive, ischemic, traumatic, hereditary, degenerative, and/or toxic-metabolic origin; the differential diagnosis between optic nerve pathologies and retinal pathologies through the use of results associated with functional examinations of the retina; and, in the distinction between cortical blindness and malingering.<xref ref-type="bibr" rid="article-143428.r16">[16]</xref><xref ref-type="bibr" rid="article-143428.r17">[17]</xref><xref ref-type="bibr" rid="article-143428.r18">[18]</xref></p>
        <p>
<bold>Neurological Field</bold>
</p>
        <p>Multiple sclerosis is an inflammatory disease of the white matter characterized by a multifocal involvement of the brain's white matter. The clinical manifestations are very variable in relation to the localization and extent of demyelination outbreaks; however, the lesions seem to have a preferential distribution in some areas of the central nervous system. In more than 20% of cases, the symptom of the onset of the disease is optic neuritis, and over 50% of patients have a clinical episode of optic neuritis. Studies have sown that VEP latency and optical coherence tomography retinal nerve layer thickness measurements correlated with disability measurements and can be useful in the management of these patients.<xref ref-type="bibr" rid="article-143428.r19">[19]</xref> The early clinical signs of MS could identify "benign" phenotypes, characterized by an almost complete recovery of vision and retinal sensibility loss in the acute phase.<xref ref-type="bibr" rid="article-143428.r20">[20]</xref><xref ref-type="bibr" rid="article-143428.r21">[21]</xref>&#x000a0;</p>
        <p>In demyelinating pathologies of the optic nerve, P-VEPs show a delay in the latency of responses, often in the absence of significant alterations of the amplitude related to the decrease in patients'&#x000a0; visual acuity. The latency alterations of the P-VEP could persist for a long time, even after the full recovery of visual acuity. It is sometimes possible to observe the delay of the latency of the P-PEV also in the contralateral eye. This alteration type can reveal the presence of sub-clinical alterations of the conduction of the impulse along the optic nerve,&#x000a0; even before clinical signs or symptoms of nerve involvement manifest.<xref ref-type="bibr" rid="article-143428.r22">[22]</xref></p>
        <p>In the ischemic neuropathy of the optic nerve, anterior ischemic optic neuropathy or AION is due to infarction of the laminar or laminar portion of the optic nerve head caused by occlusion of the short ciliary posteriors arteries. The clinical onset of this alteration is generally unexpected, without pain, and the loss of vision can progress for many days. Studies have shown VEPs useful in the management of these patients.<xref ref-type="bibr" rid="article-143428.r23">[23]</xref></p>
        <p>The campimetry deficit is typically altitudinal and may involve the central fixation area, which justifies the severe loss of visual acuity. Regarding VEP alterations, it is possible to observe a pre-dominant alteration that turns out to be the marked reduction in the amplitude of P100 associated with a poor modification of latency.<xref ref-type="bibr" rid="article-143428.r24">[24]</xref></p>
        <p>The cause of optic nerve compression is frequent optic pathway gliomas of pediatric age. The clinical onset is characterized by a gradual loss of vision without orbital pain, which may even be asymptomatic for a long time. An early clinical diagnosis and an accurate follow-up of patients with compressive neuropathy of the optic nerve, especially in the presence of meningiomas or gliomas, is of fundamental importance to improve the therapeutic approach based on surgical resection and/or radiotherapy procedures.<xref ref-type="bibr" rid="article-143428.r25">[25]</xref> In these cases, PEVs consistently exhibit a de-synchronized P100 of low amplitude with an evident latency delay.<xref ref-type="bibr" rid="article-143428.r26">[26]</xref></p>
        <p>Concerning neurodegenerative diseases, the study VEPs do not typically have a diagnostic role. These testing methods, however, can offer the possibility of investigating the physio- and pathophysiological mechanisms and the involvement of the different neurotransmission systems involved in the pathogenesis of these morbid conditions in a refined and non-invasive way.&#x000a0;</p>
        <p>Leber optic neuropathy (LON) and Kjer-type dominant optic neuritis (DON) are the most common hereditary forms of primary retinal ganglion&#x000a0;cell disease. LON typically presents a progressive loss of bilateral vision not associated with orbital tissue and is linked to mitochondrial mutations. In these cases, P-VEPs are markedly delayed, but relative maintenance of P100 morphology is possible in the initial stages of the disease.</p>
        <p>Alterations in the P100 amplitude are related to the stage and clinical form of the disease. Alterations of P-PEVs are generally preceded by the reduction of the amplitude or even by the lack of reproducibility of the N95 potential.<xref ref-type="bibr" rid="article-143428.r27">[27]</xref>&#x000a0;</p>
        <p>In Friedrich's Ataxia, PEVs are used to assess the evolution of visual function in this neurodegenerative disease, which tends to be abnormal in two-thirds of patients. The delayed latency and the increased amplitude of wave p100 is the most frequent electrophysiological alteration in this pathology.<xref ref-type="bibr" rid="article-143428.r28">[28]</xref><xref ref-type="bibr" rid="article-143428.r29">[29]</xref></p>
      </sec>
      <sec id="article-143428.s5" sec-type="Other Issues">
        <title>Other Issues</title>
        <p>
<bold>Surgical Intraoperative Monitoring</bold>
</p>
        <p>In the last few years, VEPs have been considered for intraoperative monitoring of visual function using several protocols; however, current literature and clinical evidence in this field are very limited. The use of total intravenous anesthesia, the introduction of light-emitting diode technology, electroretinography, and electroencephalography have increased the reliability of VEP neuromonitoring by enhancing the technique&#x02019;s reproducibility and interpretability and working to make it more reliable and easier to integrate it into the operative workflow.</p>
        <p>Recent studies have applied these tools in orbital and transsphenoidal surgery.<xref ref-type="bibr" rid="article-143428.r30">[30]</xref><xref ref-type="bibr" rid="article-143428.r31">[31]</xref><xref ref-type="bibr" rid="article-143428.r32">[32]</xref> (See Figures of intraoperative surgical monitoring with VEPs)</p>
      </sec>
      <sec id="article-143428.s6" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>VEP application requires an interprofessional team of healthcare professionals, including nurses, neurophysiopathology technicians, neurologists, and ophthalmologists. This team is fundamental for correctly applying this tool both in the clinical field and in intraoperative surgical monitoring. VEPs are regularly used&#x000a0;in diagnosing pre-chiasmatic, chiasmatic, and retrochiasmatic neurological pathologies.<xref ref-type="bibr" rid="article-143428.r13">[13]</xref>&#x000a0;[Level&#x000a0;3]</p>
        <p>In this scenario, the neurophysiopathology technician&#x000a0;provides for the preparation and control of the instrumentation of the equipment it is equipped with and fully manages to collect and optimize the various diagnostic methods on which, upon request, it must draw up a descriptive report from the technical aspect. (level I)</p>
        <p>Recent studies have applied VEPs in orbital and transsphenoidal surgery but without standardized protocols and homogeneous results.<xref ref-type="bibr" rid="article-143428.r30">[30]</xref><xref ref-type="bibr" rid="article-143428.r31">[31]</xref><xref ref-type="bibr" rid="article-143428.r32">[32]</xref> [Level&#x000a0;3]</p>
        <p>An interprofessional team that provides an integrated approach to patient care and comprehensive diagnostic management can help achieve the best possible outcomes. Collaboration, multidisciplinary shared decision-making, and open communication between team members are&#x000a0;key&#x000a0;elements for a proper diagnosis and a good outcome. The interprofessional care provided to the patient must use an integrated care pathway combined with an evidence-based approach to planning and evaluating all joint activities.<xref ref-type="bibr" rid="article-143428.r33">[33]</xref>&#x000a0;The earlier signs and symptoms of a complication&#x000a0;are identified, the better the prognosis and outcome. [Level&#x000a0;3]</p>
      </sec>
      <sec id="article-143428.s7">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=143428&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=143428">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/143428/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=143428">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-143428.s8">
        <fig id="article-143428.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Visual evoked potentials (VEPs) using a chessboard stimulation. Different electrodes can be used, which are placed on the scalp. The instrument is equipped with a stimulator to regulate the frequency and intensity of the light stimuli. Contributed by Marco Zeppieri, MD, PhD. Images courtesy of Elisa Ecoretti and Giada Pauletto, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="1.__VEP" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-143428.s9">
        <fig id="article-143428.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Pattern and flash visual evoked potentials (VEPs) results. Contributed by Marco Zeppieri, MD, PhD. Images courtesy of Elisa Ecoretti and Giada Pauletto, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="2.__vep__findings" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-143428.s10">
        <fig id="article-143428.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Flash stimulation pads used for surgical intraoperative monitoring. Intraoperative visual evoked potentials (VEPs) results. Contributed by Marco Zeppieri, MD, PhD. Images courtesy of Elisa Ecoretti and Giada Pauletto, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="3.__VEPs__surgical__monit" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-143428.s11">
        <title>References</title>
        <ref id="article-143428.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hoffmann</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Brands</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Behrens-Baumann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bach</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>VEP-based acuity assessment in low vision.</article-title>
            <source>Doc Ophthalmol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>135</volume>
            <issue>3</issue>
            <fpage>209</fpage>
            <page-range>209-218</page-range>
            <pub-id pub-id-type="pmid">28980154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hamilton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bach</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heinrich</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Odom</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>McCulloch</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>VEP estimation of visual acuity: a systematic review.</article-title>
            <source>Doc Ophthalmol</source>
            <year>2021</year>
            <month>Feb</month>
            <volume>142</volume>
            <issue>1</issue>
            <fpage>25</fpage>
            <page-range>25-74</page-range>
            <pub-id pub-id-type="pmid">32488810</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patterson Gentile</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Joshi</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Ciuffreda</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Arbogast</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Master</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Aguirre</surname>
                <given-names>GK</given-names>
              </name>
            </person-group>
            <article-title>Developmental Effects on Pattern Visual Evoked Potentials Characterized by Principal Component Analysis.</article-title>
            <source>Transl Vis Sci Technol</source>
            <year>2021</year>
            <month>Apr</month>
            <day>01</day>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>1</fpage>
            <pub-id pub-id-type="pmid">34003980</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Yan</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Tian</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Jia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Assessment of Human Visual Acuity Using Visual Evoked Potential: A Review.</article-title>
            <source>Sensors (Basel)</source>
            <year>2020</year>
            <month>Sep</month>
            <day>28</day>
            <volume>20</volume>
            <issue>19</issue>
            <pub-id pub-id-type="pmid">32998208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Soares</surname>
                <given-names>TS</given-names>
              </name>
              <name>
                <surname>Sacai</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Berezovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Watanabe</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Salom&#x000e3;o</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Pattern-reversal visual evoked potentials as a diagnostic tool for ocular malingering.</article-title>
            <source>Arq Bras Oftalmol</source>
            <year>2016</year>
            <season>Sep-Oct</season>
            <volume>79</volume>
            <issue>5</issue>
            <fpage>303</fpage>
            <page-range>303-307</page-range>
            <pub-id pub-id-type="pmid">27982208</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahajan</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ching</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Watson</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Davis</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Effect of sustained selective attention on steady-state visual evoked potentials.</article-title>
            <source>Exp Brain Res</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>240</volume>
            <issue>1</issue>
            <fpage>249</fpage>
            <page-range>249-261</page-range>
            <pub-id pub-id-type="pmid">34727219</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hassankarimi</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jafarzadehpur</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Mohammadi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Noori</surname>
                <given-names>SMR</given-names>
              </name>
            </person-group>
            <article-title>Low-contrast Pattern-reversal Visual Evoked Potential in Different Spatial Frequencies.</article-title>
            <source>J Ophthalmic Vis Res</source>
            <year>2020</year>
            <season>Jul-Sep</season>
            <volume>15</volume>
            <issue>3</issue>
            <fpage>362</fpage>
            <page-range>362-371</page-range>
            <pub-id pub-id-type="pmid">32864067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Montgomery</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Hayden</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Chaloner</surname>
                <given-names>FA</given-names>
              </name>
              <name>
                <surname>Cooke</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>Bear</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Stimulus-Selective Response Plasticity in Primary Visual Cortex: Progress and Puzzles.</article-title>
            <source>Front Neural Circuits</source>
            <year>2021</year>
            <volume>15</volume>
            <fpage>815554</fpage>
            <pub-id pub-id-type="pmid">35173586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ming</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>[A review of researches on decoding algorithms of steady-state visual evoked potentials].</article-title>
            <source>Sheng Wu Yi Xue Gong Cheng Xue Za Zhi</source>
            <year>2022</year>
            <month>Apr</month>
            <day>25</day>
            <volume>39</volume>
            <issue>2</issue>
            <fpage>416</fpage>
            <page-range>416-425</page-range>
            <pub-id pub-id-type="pmid">35523564</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kothari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shukla</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Bokariya</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Influence of visual angle on pattern reversal visual evoked potentials.</article-title>
            <source>Oman J Ophthalmol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>120</fpage>
            <page-range>120-5</page-range>
            <pub-id pub-id-type="pmid">25378875</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dymond</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Coger</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Serafetinides</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Data preprocessing applied to human average visual evoked potential P100-N140 amplitude, latency, and slope.</article-title>
            <source>Psychiatry Res</source>
            <year>1980</year>
            <month>Dec</month>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>315</fpage>
            <page-range>315-22</page-range>
            <pub-id pub-id-type="pmid">6936725</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yadav</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Ludlam</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Ciuffreda</surname>
                <given-names>KJ</given-names>
              </name>
            </person-group>
            <article-title>Effect of different stimulus configurations on the visual evoked potential (VEP).</article-title>
            <source>Doc Ophthalmol</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>124</volume>
            <issue>3</issue>
            <fpage>177</fpage>
            <page-range>177-96</page-range>
            <pub-id pub-id-type="pmid">22426575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>NH</given-names>
              </name>
            </person-group>
            <article-title>Low Contrast Visual Evoked Potentials for Early Detection of Optic Neuritis.</article-title>
            <source>Front Neurol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>804395</fpage>
            <pub-id pub-id-type="pmid">35572925</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thirunavu</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Mohammad</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Kandula</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Beestrum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lam</surname>
                <given-names>SK</given-names>
              </name>
            </person-group>
            <article-title>Vision Outcomes for Pediatric Patients With Optic Pathway Gliomas Associated With Neurofibromatosis Type I: A Systematic Review of the Clinical Evidence.</article-title>
            <source>J Pediatr Hematol Oncol</source>
            <year>2021</year>
            <month>May</month>
            <day>01</day>
            <volume>43</volume>
            <issue>4</issue>
            <fpage>135</fpage>
            <page-range>135-143</page-range>
            <pub-id pub-id-type="pmid">33480655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Leocani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Guerrieri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Visual Evoked Potentials as a Biomarker in Multiple Sclerosis and Associated Optic Neuritis.</article-title>
            <source>J Neuroophthalmol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>350</fpage>
            <page-range>350-357</page-range>
            <pub-id pub-id-type="pmid">30106802</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>DZ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>LZ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YZ</given-names>
              </name>
            </person-group>
            <article-title>Visual field versus visual evoked potentials in maculopathies and optic neuropathies.</article-title>
            <source>Yan Ke Xue Bao</source>
            <year>1989</year>
            <month>Jun</month>
            <volume>5</volume>
            <issue>1-2</issue>
            <fpage>52</fpage>
            <page-range>52-9</page-range>
            <pub-id pub-id-type="pmid">2485746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jurkute</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Robson</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>Electrophysiology in neuro-ophthalmology.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2021</year>
            <volume>178</volume>
            <fpage>79</fpage>
            <page-range>79-96</page-range>
            <pub-id pub-id-type="pmid">33832688</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Marcar</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Battegay</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Cheetham</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Parallel processing in human visual cortex revealed through the influence of their neural responses on the visual evoked potential.</article-title>
            <source>Vision Res</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>193</volume>
            <fpage>107994</fpage>
            <pub-id pub-id-type="pmid">34979298</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eklund</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Huang-Link</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kov&#x000e1;csovics</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Dahle</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Vrethem</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lind</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>OCT and VEP correlate to disability in secondary progressive multiple sclerosis.</article-title>
            <source>Mult Scler Relat Disord</source>
            <year>2022</year>
            <month>Dec</month>
            <volume>68</volume>
            <fpage>104255</fpage>
            <pub-id pub-id-type="pmid">36544315</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vidal-Jordana</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Montalban</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Multiple sclerosis: clinical aspects.</article-title>
            <source>Curr Opin Neurol</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>31</volume>
            <issue>6</issue>
            <fpage>752</fpage>
            <page-range>752-759</page-range>
            <pub-id pub-id-type="pmid">30300239</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Seze</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bigaut</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Multiple sclerosis diagnostic criteria: From poser to the 2017 revised McDonald criteria.</article-title>
            <source>Presse Med</source>
            <year>2021</year>
            <month>Jun</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>104089</fpage>
            <pub-id pub-id-type="pmid">34718114</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Backner</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Petrou</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Glick-Shames</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Raz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zimmermann</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Jost</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Scheel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Karussis</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Levin</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Vision and Vision-Related Measures in Progressive Multiple Sclerosis.</article-title>
            <source>Front Neurol</source>
            <year>2019</year>
            <volume>10</volume>
            <fpage>455</fpage>
            <pub-id pub-id-type="pmid">31130910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Barbano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ziccardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Correlations between visual morphological, electrophysiological, and acuity changes in chronic non-arteritic ischemic optic neuropathy.</article-title>
            <source>Graefes Arch Clin Exp Ophthalmol</source>
            <year>2021</year>
            <month>May</month>
            <volume>259</volume>
            <issue>5</issue>
            <fpage>1297</fpage>
            <page-range>1297-1308</page-range>
            <pub-id pub-id-type="pmid">33415352</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jayaraman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gandhi</surname>
                <given-names>RA</given-names>
              </name>
              <name>
                <surname>Ravi</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.</article-title>
            <source>Indian J Ophthalmol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>299</fpage>
            <page-range>299-304</page-range>
            <pub-id pub-id-type="pmid">24088641</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dotto</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Berezovsky</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sacai</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Rocha</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Fernandes</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Salom&#x000e3;o</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Visual function assessed by visually evoked potentials in adults with orbital and other primary intracranial tumors.</article-title>
            <source>Eur J Ophthalmol</source>
            <year>2021</year>
            <month>May</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>1351</fpage>
            <page-range>1351-1360</page-range>
            <pub-id pub-id-type="pmid">32468859</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bowman</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Walters</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Prise</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Handley</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Green</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mankad</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'Hare</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Dahl</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Jorgensen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Opocher</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hargrave</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Thompson</surname>
                <given-names>DA</given-names>
              </name>
            </person-group>
            <article-title>Visual outcomes and predictors in optic pathway glioma: a single centre study.</article-title>
            <source>Eye (Lond)</source>
            <year>2023</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>6</issue>
            <fpage>1178</fpage>
            <page-range>1178-1183</page-range>
            <pub-id pub-id-type="pmid">35562551</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>T&#x00103;b&#x00103;caru</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Stanca</surname>
                <given-names>HT</given-names>
              </name>
            </person-group>
            <article-title>Further advances in the diagnosis and treatment of Leber's Hereditary Optic Neuropathy - a review.</article-title>
            <source>Rom J Ophthalmol</source>
            <year>2022</year>
            <season>Jan-Mar</season>
            <volume>66</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <page-range>13-16</page-range>
            <pub-id pub-id-type="pmid">35531455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ziccardi</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Cioffi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Barbano</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gioiosa</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Falsini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Casali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Parisi</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Macular Morpho-Functional and Visual Pathways Functional Assessment in Patients with Spinocerebellar Type 1 Ataxia with or without Neurological Signs.</article-title>
            <source>J Clin Med</source>
            <year>2021</year>
            <month>Nov</month>
            <day>12</day>
            <volume>10</volume>
            <issue>22</issue>
            <pub-id pub-id-type="pmid">34830553</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodr&#x000ed;guez-Labrada</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vel&#x000e1;zquez-P&#x000e9;rez</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ortega-S&#x000e1;nchez</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pe&#x000f1;a-Acosta</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>V&#x000e1;zquez-Mojena</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Canales-Ochoa</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Medrano-Montero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Torres-Vega</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Zaldivar</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Insights into cognitive decline in spinocerebellar Ataxia type 2: a P300 event-related brain potential study.</article-title>
            <source>Cerebellum Ataxias</source>
            <year>2019</year>
            <volume>6</volume>
            <fpage>3</fpage>
            <pub-id pub-id-type="pmid">30873287</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>MacDonald</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Dong</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Uribe</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Intraoperative evoked potential techniques.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2022</year>
            <volume>186</volume>
            <fpage>39</fpage>
            <page-range>39-65</page-range>
            <pub-id pub-id-type="pmid">35772897</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Gui</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The clinical application of intraoperative visual evoked potential in recurrent craniopharyngiomas resected by extended endoscopic endonasal surgery.</article-title>
            <source>Clin Neurol Neurosurg</source>
            <year>2022</year>
            <month>Mar</month>
            <volume>214</volume>
            <fpage>107149</fpage>
            <pub-id pub-id-type="pmid">35151969</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clauser</surname>
                <given-names>LC</given-names>
              </name>
              <name>
                <surname>Tieghi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Galie'</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Franco</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Carinci</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Surgical decompression in endocrine orbitopathy. Visual evoked potential evaluation and effect on the optic nerve.</article-title>
            <source>J Craniomaxillofac Surg</source>
            <year>2012</year>
            <month>Oct</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>621</fpage>
            <page-range>621-5</page-range>
            <pub-id pub-id-type="pmid">22424910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-143428.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gutowski</surname>
                <given-names>KA</given-names>
              </name>
            </person-group>
            <article-title>Evidence-Based Medicine: Abdominoplasty.</article-title>
            <source>Plast Reconstr Surg</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>141</volume>
            <issue>2</issue>
            <fpage>286e</fpage>
            <page-range>286e-299e</page-range>
            <pub-id pub-id-type="pmid">29373443</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
